Edwin Jonathan Tucker - 07 Jun 2024 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Chief Medical Officer
Signature
/s/ Herb Cross, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
07 Jun 2024
Net transactions value
+$1,669
Form type
4
Filing time
10 Jun 2024, 18:31:44 UTC
Previous filing
20 Feb 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Award $1,669 +400 $4.17 400 07 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Remarks:

Exhibit 24 - Power of Attorney